Changchun People's Pharmaceutical Group, after years of development, has always adhered to the concept of “doing high-quality products with a positive heart and doing things for the people, and the people's pharmaceutical industry is for the people”, and has deeply cultivated the field of traditional Chinese medicine and is committed to protecting the health of the public. Participating in this meeting, the group will showcase its rich product matrix in all directions, including cold/respiratory series, pediatric medicine series, cardiovascular and cerebrovascular series, rheumatism and bone injury series, tonic series, anti-tumor series and other more than ten series of products.
Changchun People's Pharmaceutical Group was established in 1966 with the mission of inheriting the essence of Chinese national medicine for 5,000 years. After half a century of development, it now has more than a dozen production lines such as pills, tablets, capsules, granules, powders, and oral liquids, equipped with domestic advanced production equipment. Dozens of major national, provincial and municipal scientific research projects have been completed, more than 40 national approvals, more than 30 national patents, more than ten products that have won national quality awards, and more than ten technological innovation awards have been awarded.
